Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Tanya Lewis > Profile

Tanya Lewis

Affiliations

  • Director at Diamedica Therapeutics Inc. (DMAC), 2024-06-03
  • Chief Dev. Op. Officer at Replimune Group Inc. (REPL), 2023-06-16
  • Evp, Chief Reg. Affairs at Karyopharm Therapeutics Inc. (KPTI), 2021-03-02
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Replimune Group Inc.
 REPL $23.45 817 Officer 135,293 2023-06-13 Filing
Replimune Group Inc.
 REPL $24.10 12,043 Officer 136,110 2023-06-13 Filing
Replimune Group Inc.
 REPL $18.05 12,207 Officer 148,153 2023-05-16 Filing
Replimune Group Inc.
 REPL $14.59 5,473 Officer 120,360 2022-05-16 Filing
Karyopharm Therapeutics Inc.
 KPTI $15.52 2,046 Officer 4,143 2021-02-11 Filing